MARGINAL ZONE LYMPHOMA
Clinical trials for MARGINAL ZONE LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new MARGINAL ZONE LYMPHOMA trials appear
Sign up with your email to follow new studies for MARGINAL ZONE LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Keytruda trial for untreated lymphoma halted early
Disease control TerminatedThis phase II study tested the immunotherapy drug pembrolizumab (Keytruda) in 9 people with untreated follicular lymphoma or marginal zone lymphoma. The goal was to see if the drug could shrink tumors or slow the disease. However, the trial was terminated early, so we have very l…
Matched conditions: MARGINAL ZONE LYMPHOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 23, 2026 11:58 UTC
-
Chemo-Free combo for lymphoma shows promise in early trial
Disease control TerminatedThis phase 2 trial tested a combination of two drugs, pembrolizumab (Keytruda) and rituximab (Truxima), in 22 people with marginal zone lymphoma, a type of blood cancer. The goal was to see if this chemotherapy-free approach could control the disease with fewer side effects than …
Matched conditions: MARGINAL ZONE LYMPHOMA
Phase: PHASE2 • Sponsor: University of Ulm • Aim: Disease control
Last updated Jun 22, 2026 11:56 UTC
-
New lymphoma drug trial halted early after testing in 18 patients
Disease control TerminatedThis early-stage trial tested a drug called VAY736, alone or with other cancer drugs, in 18 adults with certain types of Non-Hodgkin Lymphoma that had come back or not responded to prior treatments. The main goals were to check safety and find the right dose. The study was termin…
Matched conditions: MARGINAL ZONE LYMPHOMA
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 18, 2026 11:52 UTC
-
New hope for tough lymphoma: experimental drug IPH6501 tested in early trial
Disease control TerminatedThis study tested an experimental drug called IPH6501 in 23 people with a type of blood cancer called Non-Hodgkin lymphoma that had returned or stopped responding to other treatments. The main goals were to check the drug's safety and find the best dose. The trial was stopped ear…
Matched conditions: MARGINAL ZONE LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Innate Pharma • Aim: Disease control
Last updated Jun 18, 2026 11:47 UTC
-
Promising lymphoma combo study halted early
Disease control TerminatedThis study tested a combination of two drugs, umbralisib and rituximab, as the first treatment for people with follicular lymphoma or marginal zone lymphoma. The goal was to see how many patients had their cancer completely disappear. The study was stopped early and included 18 a…
Matched conditions: MARGINAL ZONE LYMPHOMA
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
New imaging agent aims to improve lymphoma staging
Diagnosis TerminatedThis study tested a new imaging agent called [68Ga]Ga-PentixaFor to see if it could find lymphoma tumors better than the standard PET scan. The trial planned to include adults with marginal zone lymphoma who had not yet been treated. However, the study was stopped early after onl…
Matched conditions: MARGINAL ZONE LYMPHOMA
Phase: PHASE3 • Sponsor: Pentixapharm AG • Aim: Diagnosis
Last updated Jun 15, 2026 19:05 UTC